Search Results - "Andrade, Naína"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination

    Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination by Sisteré-Oró, Marta, Wortmann, Diana D. J., Andrade, Naína, Aguilar, Andres, Mayo de las Casas, Clara, Casabal, Florencia Garcia, Torres, Susana, Bona Salinas, Eduardo, Raventos Soler, Laura, Arcas, Andrea, Esparre, Carlos, Garcia, Beatriz, Valarezo, Joselyn, Rosell, Rafael, Güerri-Fernandez, Roberto, Gonzalez-Cao, Maria, Meyerhans, Andreas

    Published in Frontiers in immunology (05-07-2022)
    “…Cancer patients (CPs) have been identified as particularly vulnerable to SARS-CoV-2 infection, and therefore are a priority group for receiving COVID-19…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination

    Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination by Sisteré-Oró, Marta, Andrade, Naina, Wortmann, Diana D.J., Du, Juan, Garcia-Giralt, Natalia, González-Cao, María, Güerri-Fernández, Robert, Meyerhans, Andreas

    Published in Frontiers in immunology (26-08-2022)
    “…Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: